Yuexun Xu

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Xiaobin Cui, Shumao Zhang, Yuexun Xu et al. · Journal of Translational Medicine · 2016 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +17

Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer

Yuexun Xu, Hui Luo, Qunchao Hu et al. · Frontiers in Genetics · 2021 · 33 citations · Full text

Medicine, Genetics, Oncology +17

LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis.

Yuexun Xu, Haiyan Zhu, Hongbin Ma et al. · PubMed · 2020 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression

Rui Li, Yue Wang, Yuexun Xu et al. · International Journal of Oncology · 2019 · 13 citations · Full text

Medicine, Molecular Biology, Oncology +17